Testing the accelerator hypothesis: Body size, β-cell function, and age at onset of type 1 (autoimmune) diabetes

Diabetes Care

Volumn 29, Issue 2, 2006, Pages 290-294

  Dabelea, Dana ^a,k   D'Agostino Jr , Ralph B ^b   Mayer Davis, Elizabeth J ^c   Pettitt, David J ^d   Imperatore, Giuseppina ^e   Dolan, Larry M ^f   Pihoker, Catherine ^g   Hillier, Teresa A ^h   Marcovina, Santica M ⁱ   Linder, Barbara ^j   Ruggiero, Andrea M ^b   Hamman, Richard F ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^h CENTER FOR HEALTH RESEARCH   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^k Box C245 ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; INSULIN; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; IA 2 PROTEIN; IA-2 PROTEIN; ISOENZYME; MEMBRANE PROTEIN; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; CLINICAL STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DOSE RESPONSE; ETHNOLOGY; FEMALE; HUMAN; HYPOTHESIS; INSULIN DEPENDENT DIABETES MELLITUS; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIPLE LINEAR REGRESSION ANALYSIS; SCORING SYSTEM; UNIVARIATE ANALYSIS; BLOOD; CHILD; CLINICAL TRIAL; IMMUNOLOGY; INFANT; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OBESITY; ONSET AGE; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE OF ONSET; AUTOANTIGENS; BIRTH WEIGHT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; INSULIN-SECRETING CELLS; ISOENZYMES; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MULTIVARIATE ANALYSIS; OBESITY; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33646376936     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.02.06.dc05-1339     Document Type: Article

References (24)

1. Wilkin TJ: The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 44:914-922, 2001
2. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J: Incidence of childhood type 1 diabetes worldwide: Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23:1516-1526, 2000
3. Libman I, Arslanian S: Type 2 diabetes in childhood: the American perspective. Horm Res 59 (Suppl. 1):69-76, 2003
4. Dabelea D, Klingensmith G, Imperatore G, Mayer-Davis EJ, Lawrence JM, Pihoker C, Rodriguez BL, Hardy L, Marcovina SM, Dolan LM: Clinical and pathophysiologic heterogeneity of childhood diabetes: the SEARCH for Diabetes in Youth Study (Abstract). Diabetes 53 (Suppl. 2):A427, 2004
5. Pundziute-Lycka A, Dahlquist G, Nystrom L, Arnqvist H, Bjork E, Blohme G, Bolinder J, Eriksson JW, Sundkvist G, Ostman J, the Swedish Childhood Diabetes Study Group: The incidence of type 1 diabetes has not increased, but has shifted to a younger age-at-diagnosis in the 0-34 years group in Sweden 1983-1998. Diabetologia 45:783-791, 2002
6. Littorin B, Nystrom E, Gullberg B, Rastam L, Ostman J, Arnqvist HJ, Bjork E, Blohme G, Bolinder J, Eriksson JW, Schersten B, and Sundkvist G: Increasing body mass index at diagnosis of diabetes in young adult people during 1983-1999 in the Diabetes Incidence Study in Sweden (DISS). J Intern Med 254:251-256, 2003
7. Weets I, De Leeuw IH, Du Caju MV, Rooman R, Keymeulen B, Mathieu C, Rottiers R, Daubresse JC, Rocour-Brumioul D, Pipeleers DG, Gorus FK, Belgian DR: The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: evidence for earlier disease manifestation. Diabetes Care 25:840-846, 2002
8. Bjork E, Kampe O, Karlsson FA, Pipeleers DG, Andersson A, Hellerstrom C, Eizirik DL: Glucose regulation of the autoantigen GAD65 in human pancreatic islets. J Clin Endocrinol Metab 75:1574-1576, 1992
9. The SEARCH Study Group: SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trial 458-471, 2004
10. Betts P, Mulligan J, Ward P, Smith B, Wilkin T: Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabet Med 22:144-151, 2005
11. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC: Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661-1667, 2005
12. 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies. Int J Clin Lab Res 30:21-26, 2000
13. Heding LG: Radioimmunological determination of human C-peptide in serum. Diabetologia 11:541-548, 1975
14. Buka SL, Goldstein JM, Spartos E, Tsuang MT: The retrospective measurement of prenatal and perinatal events: accuracy of maternal recall. Schizophr Res 71:417-426, 2004
15. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL: 2000 CDC Growth charts for the United States: methods and development. Vital Health Stat 11:1-190, 2002
16. Lockwood CM, MacKinnon DP: Bootstrapping the standard error of the mediated effect (Abstract). In Proceedings of the 23rd Annual Meeting of SAS Users Group International. Cary, NC, SAS Inst., 1998
17. Kibirige M, Metcalf B, Renuka R, Wilkin TJ: Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1. Diabetes Care 26:2865-2870, 2003
18. Porter JR, Barrett TJ: Braking the accelerator hypothesis? Diabetologia 47:352-353, 2003
19. Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M, Fontana A, Kaiser N, Donath MY: Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50:1683-1690, 2001
20. Khan N, Couper JJ: Low-birth-weight infants show earlier onset of IDDM. Diabetes Care 17:653-656, 1994
21. Stene LC, Magnus P, Ronningen KS, Joner G: Diabetes-associated HLA-DQ genes and birth weight. Diabetes 50:2879-2882, 2001
22. Chaillous L, Lefevre H, Thivolet C, Boitard C, Lahlou N, Atlan-Gepner C, Bouhanick B, Mogenet A, Nicolino M, Carel JC, Lecomte P, Marechaud R, Bougneres P, Charbonnel B, Sai P: Oral insulin administration and residual β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial: Diabete Insuline Orale group. Lancet 356:545-549, 2000
23. Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crino A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G: No effect of oral insulin on residual β-cell function in recent-onset type I diabetes: IMDIAB Group. Diabetologia 43:1000-1004, 2000
24. Flegal KM: The obesity epidemic in children and adults: current evidence and research issues. Med Sci Sports Exerc 31:S509-S514, 1999